NM_005422.4:c.6062G>A
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PP3_StrongPP5_Very_Strong
The NM_005422.4(TECTA):c.6062G>A(p.Arg2021His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005422.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251478Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135912
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727246
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects TECTA function (PMID: 22718023). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TECTA protein function. ClinVar contains an entry for this variant (Variation ID: 7021). This missense change has been observed in individual(s) with autosomal dominant nonsyndromic deafness and/or clinical features of TECTA-related conditions (PMID: 12162770; Invitae). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs121909062, gnomAD 0.0009%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 2021 of the TECTA protein (p.Arg2021His). -
- -
Nonsyndromic genetic hearing loss Pathogenic:1
The p.Arg2021His variant in TECTA has been reported in 4 individuals with hearing loss and segregated with disease in 4 affected family members across two families (Iwasaki 2002 PMID: 12162770, Lin 2021 PMID: 34325055, Invitae pers. comm., LMM unpublished data). It was reported to have occurred de novo in one of the affected individuals (Invitae pers. comm.). The variant was absent from large population studies. It has been reported in ClinVar (Variation ID 7021). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In vitro functional studies provide some evidence that this variant impacts localization of the protein (Moteki 2012 PMID: 22718023); however, these types of assays may not accurately represent biological function. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal dominant nonsyndromic hearing loss. ACMG/AMP Criteria applied: PS4, PM6_Supporting, PM2_Supporting, PP1_Moderate, PP3, PS3_Supporting. -
Autosomal dominant nonsyndromic hearing loss 12 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at